Price Alert

Organon & Co. (OGN)

NYSE: OGN · Real-Time Price · USD

9.37

0.00 (0.00%)

At close: Aug 15, 2025, 10:18 AM

0.00% (1D)

Bid	9.26
Market Cap	2.43B
Revenue (ttm)	4.69B
Net Income (ttm)	555.14M
EPS (ttm)	2.69
PE Ratio (ttm)	3.48
Forward PE	2.24
Analyst	Hold

Ask	9.47
Volume	450,648
Avg. Volume (20D)	4,400,953
Open	9.23
Previous Close	9.37
Day's Range	9.23 - 9.59
52-Week Range	8.01 - 23.10
Beta	0.56

About OGN

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol OGN

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for OGN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Organon & has released their quartely earnings on Aug 5, 2025:

Revenue of $1.59B exceeds estimates by $39.26M, with -0.81% YoY decline.

EPS of 1 exceeds estimates by 0.08, with -10.71% YoY decline.

Next Earnings Release

Organon & Co. is scheduled to release its earnings on Oct 30, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

-13.13%

OGN stock has given up its prior gain. Organon sha... Unlock content with Pro Subscription

1 week ago

-13.13%

Organon shares are trading higher after the company beat Q2 estimates and raised FY25 guidance.

News

3 days ago · seekingalpha.com

Organon: Valuation Discount Offset By Structural Headwinds

Organon shares are very cheap, but weak growth, high debt, and a lack of clear catalysts make them a value trap rather than a bargain. Revenue is stagnating as new products only offset legacy declines...

2 days ago · zacks.com

Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know

Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

6 days ago · zacks.com

OGN vs. HQY: Which Stock Is the Better Value Option?

Investors interested in Medical Services stocks are likely familiar with Organon (OGN) and HealthEquity (HQY). But which of these two stocks is more attractive to value investors?

1 week ago · seekingalpha.com

Organon Q2 Earnings: It May Be Time To Desert This Sinking Ship (Downgrade)

Organon & Co.'s shrinking revenues, heavy debt, and slashed dividend make it an unattractive investment despite its low valuation metrics. The Established Brands division is in decline, and new produc...

1 week ago · fool.com

Organon (OGN) Fiscal Q2 Revenue Beats 1%

1 week ago · seekingalpha.com

Organon & Co. (OGN) Q2 2025 Earnings Call Transcript

Organon & Co. (NYSE:OGN ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants Jennifer Halchak - Corporate Participant Juan Camilo Arjona Ferreira - Executive VP, Head of R...

1 week ago · zacks.com

Organon (OGN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

The headline numbers for Organon (OGN) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates ...

1 week ago · zacks.com

Organon (OGN) Beats Q2 Earnings and Revenue Estimates

Organon (OGN) came out with quarterly earnings of $1 per share, beating the Zacks Consensus Estimate of $0.94 per share. This compares to earnings of $1.12 per share a year ago.

1 week ago · businesswire.com

Organon Reports Results for the Second Quarter Ended June 30, 2025

JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon shares results for second quarter ended June 30, 2025.

1 week ago · zacks.com

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Load More News